These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24842853)

  • 21. Assessment of an oral Mycobacterium bovis BCG vaccine and an inactivated M. bovis preparation for wild boar in terms of adverse reactions, vaccine strain survival, and uptake by nontarget species.
    Beltrán-Beck B; Romero B; Sevilla IA; Barasona JA; Garrido JM; González-Barrio D; Díez-Delgado I; Minguijón E; Casal C; Vicente J; Gortázar C; Aranaz A
    Clin Vaccine Immunol; 2014 Jan; 21(1):12-20. PubMed ID: 24173022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.
    Liang J; Teng X; Yuan X; Zhang Y; Shi C; Yue T; Zhou L; Li J; Fan X
    Mol Immunol; 2015 Aug; 66(2):392-401. PubMed ID: 25974877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress in Oral Vaccination against Tuberculosis in Its Main Wildlife Reservoir in Iberia, the Eurasian Wild Boar.
    Beltrán-Beck B; Ballesteros C; Vicente J; de la Fuente J; Gortázar C
    Vet Med Int; 2012; 2012():978501. PubMed ID: 22848869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosomes carrying mycobacterial antigens can protect mice against Mycobacterium tuberculosis infection.
    Cheng Y; Schorey JS
    Eur J Immunol; 2013 Dec; 43(12):3279-90. PubMed ID: 23943377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
    Sharpe S; White A; Sarfas C; Sibley L; Gleeson F; McIntyre A; Basaraba R; Clark S; Hall G; Rayner E; Williams A; Marsh PD; Dennis M
    Tuberculosis (Edinb); 2016 Dec; 101():174-190. PubMed ID: 27865390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipidated promiscuous peptide augments the expression of MHC-II molecules on dendritic cells and activates T cells.
    Gowthaman U; Rai PK; Zeng W; Jackson DC; Agrewala JN
    Indian J Med Res; 2013 Nov; 138(5):744-8. PubMed ID: 24434326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral Vaccination With a Formulation Combining
    Contreras M; Kasaija PD; Merino O; de la Cruz-Hernandez NI; Gortazar C; de la Fuente J
    Front Cell Infect Microbiol; 2019; 9():45. PubMed ID: 30881925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
    Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
    J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Choi S; Choi HG; Shin KW; Back YW; Park HS; Lee JH; Kim HJ
    J Immunol Res; 2018; 2018():3525302. PubMed ID: 29736404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of parenteral vaccination against tuberculosis with heat-inactivated Mycobacterium bovis in experimentally challenged goats.
    Arrieta-Villegas C; Perálvarez T; Vidal E; Puighibet Z; Moll X; Canturri A; Sevilla IA; Espada Y; Juste RA; Domingo M; Pérez de Val B
    PLoS One; 2018; 13(5):e0196948. PubMed ID: 29742150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis.
    Perdomo C; Zedler U; Kühl AA; Lozza L; Saikali P; Sander LE; Vogelzang A; Kaufmann SH; Kupz A
    mBio; 2016 Nov; 7(6):. PubMed ID: 27879332
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Stüve P; Minarrieta L; Erdmann H; Arnold-Schrauf C; Swallow M; Guderian M; Krull F; Hölscher A; Ghorbani P; Behrends J; Abraham WR; Hölscher C; Sparwasser TD; Berod L
    Front Immunol; 2018; 9():495. PubMed ID: 29675017
    [No Abstract]   [Full Text] [Related]  

  • 35. Engineering Mycobacteria for the Production of Self-Assembling Biopolyesters Displaying Mycobacterial Antigens for Use as a Tuberculosis Vaccine.
    Lee JW; Parlane NA; Rehm BHA; Buddle BM; Heiser A
    Appl Environ Microbiol; 2017 Mar; 83(5):. PubMed ID: 28087528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells.
    Demangel C; Bean AG; Martin E; Feng CG; Kamath AT; Britton WJ
    Eur J Immunol; 1999 Jun; 29(6):1972-9. PubMed ID: 10382760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.
    Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N
    Front Immunol; 2014; 5():180. PubMed ID: 24795723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. M.tuberculosis mutants lacking oxygenated mycolates show increased immunogenicity and protective efficacy as compared to M. bovis BCG vaccine in an experimental mouse model.
    Hedhli D; Denis O; Barkan D; Daffé M; Glickman MS; Huygen K
    PLoS One; 2013; 8(10):e76442. PubMed ID: 24146869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.
    Kolibab K; Yang A; Derrick SC; Waldmann TA; Perera LP; Morris SL
    Clin Vaccine Immunol; 2010 May; 17(5):793-801. PubMed ID: 20357059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.